Shares of Electro Optic Systems jumped 8.4% to A$7.45 after the Australian defence firm reported a step-change quarter that reframes its investment case. H1 2026 revenue hit approximately $169 million, a 284% increase year over year , while the order book reached $846 million at 30 June — up 84% from end-2025 and the highest in company history . For a stock that spent years burning cash and posting losses, the numbers demand attention.
• War-Driven Demand Is Filling the Order Book at an Unprecedented Pace
Ongoing global conflicts and regional tensions drove the surge, with major wins including a $175 million counter-drone weapon system order from a UAE partner and the completion of a $188 million acquisition of MARSS, a European drone-detection business.
A $23 million naval weapons contract for a new Middle East customer and $7 million in U.S. counter-drone orders also landed during the quarter. The breadth — spanning the Middle East, Europe, Australia, and North America — reduces the risk of relying on any single buyer.
• Management Has Raised Guidance, but the Hard Part Is Delivery
EOS upgraded its FY26 base-business revenue guidance to $280–$300 million, up from the prior $240–$270 million range , and that figure excludes contributions from MARSS. Defence contracts typically become reported revenue only as gear is delivered, milestones are met, and customers formally accept the work, so timing can slip between reporting periods. A record backlog is a promise, not cash in the bank.
• Profitability Is Finally Within Sight — Barely
Underlying EBITDA — earnings before interest, taxes, depreciation, and amortisation, a rough measure of operating cash flow — is expected to be positive for H1 2026 , a milestone for a company that posted negative EBITDA across all of 2025 due to ongoing investment and scale constraints . Gross margins improved to 63% in 2025 from 48% in 2024 , suggesting better pricing power on newer products.
• The Stock Has Surged, Yet Analysts Still See Upside
Over the past 12 months, EOS shares have risen 123% , yet the most recent analyst rating is a Buy with an A$11.45 price target — roughly 54% above today's price. With $256 million in available cash and $286 million in total funding , the balance sheet can support production scale-up. The question now is execution: converting an $846 million backlog into shipped product and real profit, without the supply-chain stumbles that have tripped up defence contractors before.